Fibroblast growth factor 21
Fibroblast growth factor 21 (FGF-21) is a protein found in humans and other mammals that is encoded by the FGF21 gene. This protein is a member of the fibroblast growth factor (FGF) family and its endocrine subfamily along with FGF23 and FGF15/19. FGF21 is the primary endogenous agonist of the FGF21 receptor, which is composed of the FGF receptor and co-receptor β-Klotho.
Members of the FGF family are broad-spectrum mitogens important to survival activities. FGFs are involved in biological processes throughout the body including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. FGFs act through a family of four FGF receptors. Binding is complicated and requires both interaction of the FGF molecule with an FGF receptor and binding to heparin through a heparin binding domain. Endocrine FGFs lack a heparin binding domain and thus can be released into the circulation.
FGF21 is a hepatokine, a hormone secreted primarily by the liver as shown by the Potthoff lab. Among other activities, FGF21 regulates simple sugar intake and preferences for sweet foods via signaling through FGF21 receptors in the hypothalamus and correlates with reduced dopamine neurotransmission within the nucleus accumbens. The Potthoff lab followed up on their discovery and later revealed that FGF21 signaling to the ventromedial hypothalamus suppresses sugar intake by enhancing the activity of glucose-excited and glucose-inhibited neurons in response to high, but not low, glucose levels. The Potthoff lab was also the first to demonstrate that FGF21 has direct actions on adipose tissues, where it can increase acute insulin sensitivity and glucose uptake. Initially thought of as a starvation hormone, FGF21 is now described as "an endocrine mediator of the intracellular stress response to various nutritional manipulations, including excess sugars and alcohol, caloric deficits, a ketogenic diet, and amino acid restriction".
A single-nucleotide polymorphism of the FGF21 gene – the FGF21 rs838133 variant (frequency 44.7%) – has been identified as a genetic mechanism responsible for the sweet tooth behavioral phenotype, a trait associated with cravings for sweets and high sugar consumption, in both humans and mice.